<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2007-11-3-70-76</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-918</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. EXPERIMENTAL INVESTIGATION</subject></subj-group></article-categories><title-group><article-title>ОЦЕНКА КАРДИОПРОТЕКТИВНОГО ДЕЙСТВИЯ МАЛОБЕЛКОВОЙ СОЕВОЙ ДИЕТЫ И УРОВЕНЬ НЕОРГАНИЧЕСКИХ АНИОНОВ СЫВОРОТКИ КРОВИ У СПОНТАННО-ГИПЕРТЕНЗИВНЫХ КРЫС С НЕФРЭКТОМИЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>ASSESSMENT OF CARDIOPROTECTIVE  EFFECTS OF  LOW-PROTEIN  SOY  DIET AND  LEVEL OF NONORGANIC ANIONS OF  BLOOD SERUM  IN  SPONTANEOUSLY HYPERTENSIVE  RATS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Береснева</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Beresneva</surname><given-names>O. N.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Парастаева</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Parastaeva</surname><given-names>M. M.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванова</surname><given-names>Г. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanova</surname><given-names>G. T.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубина</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zubina</surname><given-names>I. M.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кучер</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kucher</surname><given-names>A. G.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каюков</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kayukov</surname><given-names>I. G.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Научно-исследовательский институт нефрологии Санкт-Петербургского государственного университета им.акад.  И.П.Павлова; &#13;
Ин­ститут физиологии им. И.П.Павлова РАН</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>10</day><month>03</month><year>2007</year></pub-date><volume>11</volume><issue>3</issue><fpage>70</fpage><lpage>76</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Береснева О.Н., Парастаева М.М., Иванова Г.Т., Зубина И.М., Кучер А.Г., Каюков И.Г., 2007</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="ru">Береснева О.Н., Парастаева М.М., Иванова Г.Т., Зубина И.М., Кучер А.Г., Каюков И.Г.</copyright-holder><copyright-holder xml:lang="en">Beresneva O.N., Parastaeva M.M., Ivanova G.T., Zubina I.M., Kucher A.G., Kayukov I.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/918">https://journal.nephrolog.ru/jour/article/view/918</self-uri><abstract><p>ЦЕЛЬ ИССЛЕДОВАНИЯ – оценка уровня АД и индекса гипертрофии миокарда левого желудочка (ИГЛЖ), концентрации нитратов и сульфатов в сыворотке крови у спонтанно-гипертензивных крыс линии SHR, подвергнутых нефрэктомии (НЭ), на фоне стандартной диеты и при потреблении малобелковой соевой диеты. МАТЕРИАЛ И МЕТОДЫ. Эксперименты выполнены на самцах спонтанно-гипертензивных крыс линии SHR с интактными почками или подвергнутых 5/6 нефрэктомии (НЭ). Исследованы: 1. Контрольная группа (n=15) – ложнооперированные (ЛО) крысы, получавшие стандартную диету (20,16% белка животного происхождения); 2. Животные, (n=11) получавшие после НЭ стандартную диету (n=11); 3. ЛО крысы (n=10), получавшие малобелковую соевую диету (МБД), содержащую 10% соевого изолята SUPRO 760; 4. Крысы (n=11), получавшие после НЭ МБД. Через 2 месяца после НЭ или ЛО у животных измеряли артериальное давление, подсчитывали частоту сердечных сокращений, сыворотке крови определяли содержание нитратов (NO₃¯, мг/л) и сульфатов (SO₄²¯, мг/л), оценивали степень гипертрофии сердца, миокарда левого желудочка, печени, селезенки. РЕЗУЛЬТАТЫ. У крыс SHR, получавших стандартную диету, НЭ приводила к росту АД и ИГЛЖ по сравнению с контролем. Малобелковая соевая диета предотвращала рост среднего АД и ИГЖЛ у крыс с НЭ. Соевая диета снижала ИГ печени у ОЛ животных и крыс с НЭ по сравнению с контрольной группой, получавшей стандартную диету. Существенных различий по уровню NO₃¯ между анализируемыми группами не выявлено. ЗАКЛЮЧЕНИЕ. МБД, включающая соевый белковый изолят SUPRO 760, обладает кардиопротективным действием у спонтанно-гипертензивных крыс с экспериментальной почечной недостаточностью, уменьшая выраженность гипертрофии миокарда и предотвращая рост среднего АД.</p></abstract><trans-abstract xml:lang="en"><p>THE AIM of the investigation was to assess the level of AP and the left ventricle hypertrophy index (LVHI), concentration of nitrates and sulfates in blood serum of spontaneously hypertensive SHR rats subjected to nephrectomy (NE) against the background of standard diet and low-protein soy diet (LPSD). MATERIAL AND METHODS. Experiments were fulfilled in male spontaneously hypertensive SHR rats with intact kidneys or subjected to 5/6 NE. The following investigations were carried out: 1.A control group (n=15) – sham-operated (ShO) rats receiving a standard diet (20.16% of the animal origin protein); 2. Animals (n=11) receiving the standard diet after NE; 3. ShO rats (n=10) receiving LPSD containing10% soy isolate SUPRO 760; 4. Rats (n=11) receiving LPSD after NE. In two months after NE and sham operation the following investigations were made in the animals: measurement of arterial pressure, heart rate, content of nitrates (NO₃¯, mg/l) and sulfates (SO₄²¯, mg/l) in blood serum, the degree of hypertrophy of the heart, left ventricle myocardium, liver, spleen. RESULTS. In SHR rats, receiving the standard diet, NE resulted in growing AP and LVHI as compared with controls. LPSD prevented the growth of mean AP and LVHI3 in the rats with NE. Soy diet decreased the hypertrophy index of the liver in ShO animals and NE rats as compared with the controls given the standard diet. No substantial differences in the level of NO₃¯ were found between the analyzed groups. CONCLUSION. LPSD including the soy isolate SUPRO 760 has a cardioprotecting effect in spontaneously hypertensive rats with experimental renal failure due to decreased myocardium hypertrophy and prevention of mean AP growth.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>экспериментальная почечная недостаточность</kwd><kwd>малобелковая соевая дие­та</kwd><kwd>миокард</kwd><kwd>нитраты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>experimental renal failure</kwd><kwd>low-protein soy diet</kwd><kwd>myocardium</kwd><kwd>nitrates</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов АВ. Добронравов ВА, Каюков ИГ. Кардио-ренальный континуум: патологические основы превентивной нефрологии. Нефрология 2005; 9(3):7-15</mixed-citation><mixed-citation xml:lang="en">Смирнов АВ. Добронравов ВА, Каюков ИГ. Кардио-ренальный континуум: патологические основы превентивной нефрологии. Нефрология 2005; 9(3):7-15</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Perera GA. Hypertensive vascular disease: description and natural history. J Chron Dis 1955; 1: 33-42</mixed-citation><mixed-citation xml:lang="en">Perera GA. Hypertensive vascular disease: description and natural history. J Chron Dis 1955; 1: 33-42</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">U.S. Renal Data System. USDRS 2001. Annual Data Report, Bethesda, M.D., National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2001</mixed-citation><mixed-citation xml:lang="en">U.S. Renal Data System. USDRS 2001. Annual Data Report, Bethesda, M.D., National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2001</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов АВ, Добронравов ВА, Румянцев АШ и др. Факторы риска ИБС у больных, получающих лечение гемодиализом. Нефрология 2003; 7(приложение 1): 7-13</mixed-citation><mixed-citation xml:lang="en">Смирнов АВ, Добронравов ВА, Румянцев АШ и др. Факторы риска ИБС у больных, получающих лечение гемодиализом. Нефрология 2003; 7(приложение 1): 7-13</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Anavekar NS, Me Murray JV, Velazguez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:13</mixed-citation><mixed-citation xml:lang="en">Anavekar NS, Me Murray JV, Velazguez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:13</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Anavekar NS, Preffer MA. Cardiovascular risk in chronic kidney disease. Kidney Int 2004; 66 [Suppl 92]: S11-S15</mixed-citation><mixed-citation xml:lang="en">Anavekar NS, Preffer MA. Cardiovascular risk in chronic kidney disease. Kidney Int 2004; 66 [Suppl 92]: S11-S15</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Жлоба АА. Спектрофотометрические методы измерения в клинической энзимологии. Изд-во СПбГМУ, СПб, 2005; 29-32</mixed-citation><mixed-citation xml:lang="en">Жлоба АА. Спектрофотометрические методы измерения в клинической энзимологии. Изд-во СПбГМУ, СПб, 2005; 29-32</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Кучер АГ. Проблемы лечебного питания у больных с ХПН. Нефрология 1997; 1: 39-45</mixed-citation><mixed-citation xml:lang="en">Кучер АГ. Проблемы лечебного питания у больных с ХПН. Нефрология 1997; 1: 39-45</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Passey C, Bunker V, Jackson A, Lee H. Energy balance in predialysis patients on a low-protein diet. J Ren Nutr 2003; 13(2): 120-125</mixed-citation><mixed-citation xml:lang="en">Passey C, Bunker V, Jackson A, Lee H. Energy balance in predialysis patients on a low-protein diet. J Ren Nutr 2003; 13(2): 120-125</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fournier DB, Erdman JW, Gordon GB. Soy, its components and cancer prevention: a review of the in vitro, animal and human data. Cancer Epidemiology, Biomarkers Prevention (Baltimore) 1998; 7(11): 1055-1065</mixed-citation><mixed-citation xml:lang="en">Fournier DB, Erdman JW, Gordon GB. Soy, its components and cancer prevention: a review of the in vitro, animal and human data. Cancer Epidemiology, Biomarkers Prevention (Baltimore) 1998; 7(11): 1055-1065</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia M, Torre M, Marina ML et al. Composition and characterization of soyabean and related products. Crit Rev Food Sci Nutr 1997; 37(4): 361-391</mixed-citation><mixed-citation xml:lang="en">Garcia M, Torre M, Marina ML et al. Composition and characterization of soyabean and related products. Crit Rev Food Sci Nutr 1997; 37(4): 361-391</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Хенли ЕС, Кустер ДМ. Оценка качества белка с помощью скорректированного аминокислотного коэффициента усвояемости белка. Соевые белки СУПРО в клинической медицине. М.: Протеин Технолоджис Инт 1999: 5-13</mixed-citation><mixed-citation xml:lang="en">Хенли ЕС, Кустер ДМ. Оценка качества белка с помощью скорректированного аминокислотного коэффициента усвояемости белка. Соевые белки СУПРО в клинической медицине. М.: Протеин Технолоджис Инт 1999: 5-13</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Tonstad S, Smerud K, Hoie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 2002; 76(1):78-84</mixed-citation><mixed-citation xml:lang="en">Tonstad S, Smerud K, Hoie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 2002; 76(1):78-84</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fair DE, Ogborn MR, Weiler HA et al. Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in: SPRD-cy weanling rats. J Nutr 2004; 134(6): 1504-1507</mixed-citation><mixed-citation xml:lang="en">Fair DE, Ogborn MR, Weiler HA et al. Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in: SPRD-cy weanling rats. J Nutr 2004; 134(6): 1504-1507</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Messina M, Gardner C, Barnes S. Gaining insight into the health effects of soy but a long way still to go; commentary on the fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. G Nutr 2002; 132( 2): 547S-551S</mixed-citation><mixed-citation xml:lang="en">Messina M, Gardner C, Barnes S. Gaining insight into the health effects of soy but a long way still to go; commentary on the fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. G Nutr 2002; 132( 2): 547S-551S</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Pedraza-Chaverri J, Barrera D, Hernandez-Pando R et al. Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced by puromycin aminonucleoside. Life Sci 2004; 74(8): 987-999</mixed-citation><mixed-citation xml:lang="en">Pedraza-Chaverri J, Barrera D, Hernandez-Pando R et al. Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced by puromycin aminonucleoside. Life Sci 2004; 74(8): 987-999</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wu J, Ding X. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. J Agric Food Chem 2001; 49(1): 501-506</mixed-citation><mixed-citation xml:lang="en">Wu J, Ding X. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. J Agric Food Chem 2001; 49(1): 501-506</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ni W, Tsuda Y, Takashima S et al. Antiatherogenic effect of soya and rice-protein isolate, compared with casein, in apolipoprotein E-deficient mice. Br J Nutr 2003; 90(1):13-20</mixed-citation><mixed-citation xml:lang="en">Ni W, Tsuda Y, Takashima S et al. Antiatherogenic effect of soya and rice-protein isolate, compared with casein, in apolipoprotein E-deficient mice. Br J Nutr 2003; 90(1):13-20</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sirtori CR, Gianazza E, Manzoni C et al. Role of isoflavones in the cholesterol reduction by soy proteins in the clinic. Am J Clin Nutr 1997; 65(1):166-167</mixed-citation><mixed-citation xml:lang="en">Sirtori CR, Gianazza E, Manzoni C et al. Role of isoflavones in the cholesterol reduction by soy proteins in the clinic. Am J Clin Nutr 1997; 65(1):166-167</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Комарова НВ, Каменцев ЯС. Практическое руководство по использованию систем капиллярного электрофореза «Капель». ООО «Веда», СПб, 2006</mixed-citation><mixed-citation xml:lang="en">Комарова НВ, Каменцев ЯС. Практическое руководство по использованию систем капиллярного электрофореза «Капель». ООО «Веда», СПб, 2006</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Okoshi K, Ribeiro HB, Okoshi MP et al. Improved systolic ventricular function with normal myocardial mechanics in compensated cardiac hypertrophy. Jpn Heart J 2004; 45(4): 647-656</mixed-citation><mixed-citation xml:lang="en">Okoshi K, Ribeiro HB, Okoshi MP et al. Improved systolic ventricular function with normal myocardial mechanics in compensated cardiac hypertrophy. Jpn Heart J 2004; 45(4): 647-656</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Шутов АМ, Куликова ЕС, Кондратьева НИ. Гипертрофия левого желудочка у больных в додиализном периоде хронической почечной недостаточности, не связанной с сахарным диабетом. Нефрология 2001; 5(5): 49-53</mixed-citation><mixed-citation xml:lang="en">Шутов АМ, Куликова ЕС, Кондратьева НИ. Гипертрофия левого желудочка у больных в додиализном периоде хронической почечной недостаточности, не связанной с сахарным диабетом. Нефрология 2001; 5(5): 49-53</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Bennett SJ, Welch JL, Eckert GJ et al. Nutrition in chronic heart failure with coexisting chronic kidney disease. J Cardiovasc Nurs 2006; 21: 56-62</mixed-citation><mixed-citation xml:lang="en">Bennett SJ, Welch JL, Eckert GJ et al. Nutrition in chronic heart failure with coexisting chronic kidney disease. J Cardiovasc Nurs 2006; 21: 56-62</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Nuhbegrovic S, Halibasic A, Karamehic J. Morphologic changes in the interventricular septum and the posterior wall of the left ventricle in patients on hemodialysis. Med Arh 2000; 54(2): 69-70</mixed-citation><mixed-citation xml:lang="en">Nuhbegrovic S, Halibasic A, Karamehic J. Morphologic changes in the interventricular septum and the posterior wall of the left ventricle in patients on hemodialysis. Med Arh 2000; 54(2): 69-70</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">London GM. Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transpl 2001; 16 [Suppl 2]: 3-6</mixed-citation><mixed-citation xml:lang="en">London GM. Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transpl 2001; 16 [Suppl 2]: 3-6</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">MacGowan GC, Wieczorek DF. Compensatory changes in Ca and myocardial O2 consumption in beta-tropomyosin transgenic hearts. Am J Physiol Heart Circulatory 2001; 281(6): H2539-2548</mixed-citation><mixed-citation xml:lang="en">MacGowan GC, Wieczorek DF. Compensatory changes in Ca and myocardial O2 consumption in beta-tropomyosin transgenic hearts. Am J Physiol Heart Circulatory 2001; 281(6): H2539-2548</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Барабанова ВВ, Береснева ОН. Является ли паратиреоидный гормон основным повреждающим фактором сосудов печени при экспериментальной почечной недостаточности. Нефрология 1998; 2(1): 99-104</mixed-citation><mixed-citation xml:lang="en">Барабанова ВВ, Береснева ОН. Является ли паратиреоидный гормон основным повреждающим фактором сосудов печени при экспериментальной почечной недостаточности. Нефрология 1998; 2(1): 99-104</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Qing DP, Ding H, Vadgama J et al. Elevated myocardial cytosolic calcium impairs insulin-like growth factor-1-stimulated protein synthesis in chronic renal failure. J Am Soc Nephrol 1999; 10(1): 84-92</mixed-citation><mixed-citation xml:lang="en">Qing DP, Ding H, Vadgama J et al. Elevated myocardial cytosolic calcium impairs insulin-like growth factor-1-stimulated protein synthesis in chronic renal failure. J Am Soc Nephrol 1999; 10(1): 84-92</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Amman K, Torning J, Flechtenmacher C et al. Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uremia: evidence for a permissive action of PTH. Nephrol Dial Transpl 1995; 10: 2043-2048</mixed-citation><mixed-citation xml:lang="en">Amman K, Torning J, Flechtenmacher C et al. Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uremia: evidence for a permissive action of PTH. Nephrol Dial Transpl 1995; 10: 2043-2048</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Ильичева ОЕ. Факторы риска развития хронической сердечной недостаточности у пациентов с различными стадиями хронической болезни почек. Нефрология 2007; 11(1): 71-78</mixed-citation><mixed-citation xml:lang="en">Ильичева ОЕ. Факторы риска развития хронической сердечной недостаточности у пациентов с различными стадиями хронической болезни почек. Нефрология 2007; 11(1): 71-78</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Channon KM, Qian H, George SE. Nitric oxide synthase in atherosclerosis and vascular injury. Arteroscler Thromb Vasc Biol 2000; 20(8): 1873-1881</mixed-citation><mixed-citation xml:lang="en">Channon KM, Qian H, George SE. Nitric oxide synthase in atherosclerosis and vascular injury. Arteroscler Thromb Vasc Biol 2000; 20(8): 1873-1881</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Wu J, Ding X. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. J Agric Food Chem 2001; 49(1): 501-506</mixed-citation><mixed-citation xml:lang="en">Wu J, Ding X. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. J Agric Food Chem 2001; 49(1): 501-506</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003; 41 [Suppl 5]: 11-17</mixed-citation><mixed-citation xml:lang="en">Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003; 41 [Suppl 5]: 11-17</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Combe C, Aparicio M. Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int 1994; 46: 1381-1386</mixed-citation><mixed-citation xml:lang="en">Combe C, Aparicio M. Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int 1994; 46: 1381-1386</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ranich T, Bhathena SJ, Velasquez MT. Protective effects of dietary phytoestrogens in chronic renal disease. J Ren Nutr 2001; 11(4): 183-193</mixed-citation><mixed-citation xml:lang="en">Ranich T, Bhathena SJ, Velasquez MT. Protective effects of dietary phytoestrogens in chronic renal disease. J Ren Nutr 2001; 11(4): 183-193</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
